◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

IOVANCE BIOTHERAPEUTICS, INC.

CIK: 1425205 SIC: 2836
$263.50M
Revenue
$-390.98M
Net Income
28.66%
Gross Margin
-153.08%
Op. Margin
$-630.96M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 15 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $263.50M $263.50M $164.07M $1.19M - -
Revenue Growth % 0.0% 60.6% 13699.0% nan% nan% nan%
Cost of Revenue $187.99M $173.18M $93.25M $1.03M - -
+ Gross Profit $75.51M $90.32M $70.82M $156.00K - -
Gross Margin % 28.7% 34.3% 43.2% 13.1% nan% nan%
Operating Expenses $666.86M $666.86M $559.35M $461.75M $398.88M $342.70M
Research & Development $302.62M $300.27M $276.23M $333.19M $294.78M $259.04M
+ Operating Income $-403.36M $-403.36M $-395.28M $-460.56M $-398.88M $-342.70M
Operating Margin % -153.1% -153.1% -240.9% -38735.0% nan% nan%
Interest Income $10.31M $10.31M $20.27M $13.04M $2.98M $451.00K
Income Before Tax $-393.05M $-393.05M $-375.00M $-447.52M $-395.89M $-342.25M
Income Tax Expense $-2.07M $-2.07M $-2.83M $-3.48M - -
+ Net Income $-390.98M $-390.98M $-372.18M $-444.04M $-395.89M $-342.25M
Net Margin % -148.4% -148.4% -226.8% -37345.4% nan% nan%
Basic EPS -1.09 -1.09 -1.28 -1.89 -2.49 -2.23
Diluted EPS nan -1.09 -1.28 -1.89 -2.49 -2.23
Basic Shares Outstanding - 357K 290K 235K 159K 153K
Diluted Shares Outstanding - 357K 290K 235K 159K 153K
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $163.08M $115.69M $114.89M $231.73M $78.23M
Short-term Investments $133.90M $208.09M $164.98M $240.11M $426.18M
Accounts Receivable $82.45M $69.34M $151.00K - -
Inventory $51.68M $51.52M $10.37M - -
Other Current Assets $11.58M $12.38M $17.46M $7.27M $3.55M
Total Current Assets $442.69M $457.02M $307.85M $479.12M $507.96M
Property Plant & Equipment $131.11M $109.08M $114.03M $105.23M $100.94M
Intangible Assets $279.32M $282.40M $229.26M - -
Long-term Investments - - - - $91.59M
Other Non-current Assets $8.17M $369.00K $270.00K $189.00K $1.78M
Total Assets $913.17M $910.43M $780.35M $663.98M $777.33M
Accounts Payable $22.16M $27.51M $33.12M $26.60M $27.38M
Accrued Liabilities $111.16M $81.94M $69.41M $52.30M $56.77M
Total Current Liabilities $138.36M $122.34M $110.31M $91.48M $89.20M
Deferred Tax Liabilities $31.83M $32.31M $17.35M - -
Total Liabilities $214.59M $200.02M $195.74M $164.34M $155.67M
Common Stock $17.00K $13.00K $11.00K $8.00K $7.00K
Retained Earnings $-2.78B $-2.38B $-2.01B $-1.57B $-1.17B
Total Stockholders Equity $698.58M $710.40M $584.61M $499.64M $621.66M
Total Liabilities & Equity $913.17M $910.43M $780.35M $663.98M $777.33M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-507.14M $-390.98M $-372.18M $-444.04M $-395.89M $-342.25M
Depreciation & Amortization $19.05M $12.86M $11.26M $11.57M $9.31M $3.11M
Stock-based Compensation $84.49M $61.58M $109.63M $62.62M $84.02M $69.77M
Deferred Income Tax $-3.76M $-2.07M $-2.83M $-3.48M - -
Change in Receivables $5.30M $13.11M $69.19M $149.00K - -
Change in Inventory $35.21M $14.21M $44.38M $10.12M - -
Change in Payables $-1.66M $-6.66M $-7.84M $4.83M $5.88M $6.98M
Operating Cash Flow $-577.24M $-302.41M $-352.98M $-361.82M $-292.76M $-227.94M
Capital Expenditure $53.72M $33.84M $11.07M $22.29M $20.43M $37.57M
Acquisitions - - - $212.63M - -
Investing Cash Flow $93.07M $47.50M $-96.41M $-155.24M $256.45M $132.00K
Stock Issued $617.26M $306.31M $397.30M $463.28M $189.50M $203.16M
Financing Cash Flow $600.63M $300.77M $390.66M $462.96M $190.15M $239.27M
Net Change in Cash $119.36M $47.01M $-59.27M $-56.84M $153.85M $11.46M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $67.45M $58.55M $176.73M $90.38M
Cost of Revenue $38.48M $31.52M $130.07M $55.46M
Operating Expenses $162.36M $147.62M $506.63M $399.08M
Research & Development $75.17M $67.04M $229.07M $205.22M
Operating Income $-94.90M $-89.07M $-329.90M $-308.70M
Interest Income $1.24M $4.00M $8.57M $10.70M
Income Before Tax $-93.66M $-85.06M $-321.33M $-298.00M
Income Tax Expense $-2.40M $-1.52M $-2.25M $-4.39M
Net Income $-91.25M $-83.54M $-319.07M $-293.62M
Basic EPS -0.25 -0.28 -0.94 -1.03
Basic Shares Outstanding $364.04K $303.27K $340.62K $284.84K
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $158.13M $115.69M
Short-term Investments $142.67M $208.09M
Accounts Receivable $66.76M $69.34M
Inventory $51.71M $51.52M
Other Current Assets $9.82M $12.38M
Total Current Assets $429.09M $457.02M
Property Plant & Equipment $126.65M $109.08M
Intangible Assets $285.21M $282.40M
Other Non-current Assets $9.27M $369.00K
Total Assets $904.95M $910.43M
Accounts Payable $31.24M $27.51M
Total Current Liabilities $125.78M $122.34M
Deferred Tax Liabilities $31.66M $32.31M
Total Liabilities $202.66M $200.02M
Common Stock $16.00K $13.00K
Retained Earnings $-2.70B $-2.38B
Total Stockholders Equity $702.29M $710.40M
Total Liabilities & Equity $904.95M $910.43M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-91.25M $-83.54M $-319.07M $-293.62M
Depreciation & Amortization $9.01M $9.73M $9.14M $7.98M
Stock-based Compensation $11.90M $31.01M $49.76M $78.65M
Deferred Income Tax - - $-2.25M $-4.39M
Change in Receivables - - $-2.58M $55.62M
Change in Inventory - - $10.21M $25.45M
Change in Payables - - $-1.45M $-1.77M
Operating Cash Flow - - $-249.84M $-279.68M
Capital Expenditure - - $24.52M $6.90M
Investing Cash Flow - - $46.72M $-120.09M
Stock Issued - - $250.53M $397.30M
Financing Cash Flow - - $244.60M $388.36M
Net Change in Cash - - $42.05M $-10.78M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...